NMR Assays for Estimating the O‑Acetyl Content of Meningococcal Polysaccharide Serogroup A in Quadrivalent Conjugate Vaccine Formulation

NMR Assays for Estimating the O‑Acetyl Content of Meningococcal Polysaccharide Serogroup A in Quadrivalent Conjugate Vaccine Formulation

Bibliographic Details
Main Authors:	Silvia Martini, Marianna Aggravi, Simona Cianetti, William Egan, Malte Meppen, Alessio Moriconi, Luca Simeone, Francesco Berti
Format:	Article
Language:	English
Published:	American Chemical Society 2019-07-01
Series:	ACS Omega
Online Access:	http://dx.doi.org/10.1021/acsomega.9b01678

Similar Items

Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine.
by: Mariëtte B van Ravenhorst, et al.
Published: (2018-01-01)

Immunogenicity and safety of a quadrivalent meningococcal polysaccharide CRM conjugate vaccine in infants and toddlers
by: Miguel Tregnaghi, et al.
Published: (2014-09-01)

Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
by: Kadidja Gamougam, et al.
Published: (2015-01-01)

Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity
by: Maiden, Martin C.J, et al.
Published: (2008)

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil
by: Márcia de Cantuária Tauil, et al.
Published: (2014-07-01)

Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.
by: Rolando Pajon, et al.
Published: (2013-01-01)

Meningococcal disease serogroup C
by: Cuevas IE, et al.
Published: (2012-03-01)

Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo&reg;) in the context of treatment and prevention of invasive disease
by: Br&ouml;ker M, et al.
Published: (2011-07-01)

Meningococcal disease in England and Wales : analysing the impact of serogroup C conjugate vaccination
by: Trotter, Caroline Louise
Published: (2004)

Instruction for Medical Use Drug MENAKTRA (Vaccine Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Conjugated to Diphtheria Toxoid)
by: Editorial Article
Published: (2016-04-01)

Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease
by: Sanford R Kimmel
Published: (2008-09-01)

Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada.
by: Thomas E Delea, et al.
Published: (2017-01-01)

Serogroup Y Meningococcal Disease, Colombia
by: Clara Inés Agudelo, et al.
Published: (2008-06-01)

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
by: Hedari CP, et al.
Published: (2014-04-01)

Meningococcal disease. Meningococcal conjugate polysaccharide vaccines and new generation vaccines. Report 3
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Immunogenicity and safety of a novel quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) in healthy Korean adolescents and adults
by: Hoan Jong Lee, et al.
Published: (2014-11-01)

The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology
by: Luiz Silva JD, et al.
Published: (2010-06-01)

Toward an Improved Meningococcal Serogroup B Assay
by: Jan Poolman
Published: (2018-05-01)

Serogroup X in Meningococcal Disease, Western Kenya
by: Sadiki Materu, et al.
Published: (2007-06-01)

Safety and Immunogenicity of Two Doses of Quadrivalent Meningococcal Conjugate Vaccine or One Dose of Meningococcal Group C Conjugate Vaccine, both Administered Concomitantly with Routine Immunization to 12- to 18-Month-Old Children
by: Francisco Noya, et al.
Published: (2014-01-01)

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands
by: Kaaijk Patricia, et al.
Published: (2012-02-01)

Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands.
by: Hiltsje Hepkema, et al.
Published: (2013-01-01)

An unexpected fever post serogroup B meningococcal sepsis
by: Daniele Donà, et al.
Published: (2016-11-01)

CC4821 serogroup W meningococcal disease in China
by: Baohua He, et al.
Published: (2014-12-01)

Serogroup W135 Meningococcal Disease, The Gambia, 2012
by: M. Jahangir Hossain, et al.
Published: (2013-09-01)

[Meningococcal meningitis: a case of serogroup W in an underage migrant]
by: Silvia Dari, et al.
Published: (2017-06-01)

Breaking barriers in the fight against meningococcal serogroup B disease
by: F. Martinón-Torres
Published: (2014-04-01)

Serogroup W-135 Meningococcal Disease during the Hajj, 2000
by: Jairam R. Lingappa, et al.
Published: (2003-06-01)

Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine When Co-Administered with Tetanus-Reduced Diphtheria-Acellular Pertussis and Quadrivalent Meningococcal Conjugate Vaccines in Healthy Adolescents: Results from a Randomized, Observer-Blind, Controlled Trial
by: Yan Miao, et al.
Published: (2019-08-01)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
by: Rivero-Calle I, et al.
Published: (2019-10-01)

Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine.
by: Richarda M de Voer, et al.
Published: (2010-01-01)

Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt.
by: Andreas Kuznik, et al.
Published: (2017-01-01)

Estimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine Introduction
by: Domenico Martinelli, et al.
Published: (2015-01-01)

Clinical cases of meningococcal infection caused by Neisseria meningitidis serogroup W
by: N. V. Skripchenko, et al.
Published: (2019-11-01)

The Course of Generalized Meningococcal Infection Caused by Meningococcus Serogroup W135
by: M. V. Ivanova, et al.
Published: (2016-11-01)

Increase in Meningococcal Serogroup W Disease, Victoria, Australia, 2013–2015
by: Kylie S. Carville, et al.
Published: (2016-10-01)

Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
by: Amit Srivastava, et al.
Published: (2020-07-01)

Serogroup W135 Meningococcal Meningitis, Northern Cameroon, 2007–2008
by: Denis Massenet, et al.
Published: (2009-02-01)

Modelling the impact of vaccination targeted against serogroup B meningococcal disease
by: Christensen, Hannah
Published: (2011)

Are Physicians Obligated to Tell Parents about the Meningococcal Serogroup B Vaccine?
by: Dr Joan L Robinson
Published: (2015-01-01)

Cannot write session to /tmp/vufind_sessions/sess_otp7pkpdpd082ep8862mivok3o